EP3989964
TASIMELTEON USE IN TREATING SLEEP ABERRATIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
29.6.2020:
19.2.2025:
20742604.0
:
28.6.2040
:
TASIMELTEON USE IN TREATING SLEEP ABERRATIONS
29.6.2020
19.2.2025
:
Vanda Pharmaceuticals Inc.:
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, US
:
POLYMEROPOULOS, Mihael:
Potomac, MD 20854, US
:
SMIESZEK, Sandra:
Washington, DC 20037, US
:
201962868881 P:
29.6.2019:
US
:
US2020040081:
29.6.2020
:
A61K 31/343, A61K 31/55, A61K 33/00, A61P 25/00, A61P 43/00